|
O.D. Ostroumova (1, 2), A.I. Kochetkov (1)
The role of the disturbances in the intestinal barrier structure in relation to cardiovascular diseases pathogenesis and rebamipid potential in their correction
|
№13 / 2020
|
|
E.A. Aseeva (1), S.K. Soloviev (2), N.Yu. Nikishina (2), E.L. Nasonov (1), A.M. Lila (1)
Standard and innovative treatments for systemic lupus erythematosus
|
№13 / 2020
|
|
K.B. Mirzaev (1), V.M. Tsvetov (2)
Scientific rationale for the use of remdesivir in patients with COVID-19
|
№13 / 2020
|
|
I.S. Burashnikova (1), V.M. Tsvetov (2)
Drug therapy for asymptomatic carriers of SARS-CoV-2
|
№13 / 2020
|
|
Yu.Yu. Kiselev (1), K.B. Mirzaev (2)
Possibilities of using glucocorticosteroids in the outpatient treatment of patients with COVID-19
|
№13 / 2020
|
|
V.F. Rusakov (1), D.V. Rebrova (1), N.I. Timofeeva (1), A.A. Belousova (1), T.V. Savelyeva (1), R.A. Chernikov (1), I.V. Sleptsov (1), T.S. Pridvizhkina (1), N.V. Vorokhobina (2), Yu.N. Fedotov (1)
Acromegaly and diffuse multinodular goiter: clinical cases
|
№12 / 2020
|
|
L.Yu. Khamnueva (1), L.S. Andreeva (1), A.V. Davydova (1), E.V. Chugunova (1), N.P. Tokareva (2), N.Yu. Molodtsova (1)
The use of fixed ratio combination of insulin glargine and lixisenatide in patients with type 2 diabetes mellitus in real clinical practice. Own clinical experience
|
№12 / 2020
|
|
E.V. Pronin (1), V.S. Pronin (2)
Contribution of somatostatin analogues to the implementation of a patient-oriented approach to the treatment of acromegaly
|
№12 / 2020
|
|
M.B. Antsiferov (1), G.R. Galstyan (2)
Resolution on the results of the expert panel “IDegLira: is it 1+1 or anything more?”
|
№12 / 2020
|
|
L.I. Shevchenko, Kh. Ya. Karimov, T.R. Alimov, O. V. Lubentsova, M.N. Ibragimov
The effect of a new amino acid agent on protein metabolism, the intensity of lipid peroxidation and the state of the antioxidant system in experimental protein-energy deficiency
|
№12 / 2020
|
|
E.V. Shchukina (1), V.D. Gromenkov (2), Y.V. Suprun (2), I.S. Mykhailichenko (1), E.V. Beryozova (2), V.A. Bagriy (3), I.A. Golodnikov (1)
Vasodilating beta-adrenoceptor blockers in post-myocardial infarction patients with type 2 diabetes
|
№12 / 2020
|
|
T.P. Demicheva
Possibilities of using taurine in the treatment of psychovegetative disorders in patients with type 2 diabetes mellitus
|
№12 / 2020
|
Русский
